-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease Update and Reception

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI)
Monday, December 12, 2022: 6:00 PM-8:00 PM
Gravier DEF (Marriott New Orleans Warehouse Arts District)
All meeting attendees interested in sickle cell disease are invited to attend the ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease Update and Reception. In 2015, ASH launched a transformative, multi-faceted, patient-centric initiative to improve outcomes for individuals living with sickle cell disease (SCD). ASH’s multifaceted SCD efforts are focused on:   

  • Convening multidisciplinary partners and collaborators 
  • Promoting access to high quality care 
  • Global issues 
  • Policy and advocacy 
  • Research 
  • Leveraging data

Please join us for an evening of networking and to learn about the ASH and ASH Research Collaborative SCD programs and how to be a part of this nationwide and global initiative.

ASH Sickle Cell Disease Programs

Robert Brodsky, MD

Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD
ASH RC Sickle Cell Disease Clinical Trials Network

Charles S. Abrams, MD

University of Pennsylvania, Philadelphia, PA
ASH RC Data Hub and Learning Community Programs

Alexis A. Thompson, MD, MPH

Children's Hospital of Philadelphia, Philadelphia, PA
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>